{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T22:03:32Z","timestamp":1782425012540,"version":"3.54.5"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>Antiretroviral therapy has revolutionized HIV treatment with didanosine (DDI) as a pioneering drug. However, DDI has been associated with retinal toxicity, characterized by peripheral chorioretinal degeneration with macular sparing. Despite its clinical recognition, the prevalence and risk factors for didanosine-induced retinopathy are not well described.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This retrospective case series analyzed 127 DDI-treated patients at Weill Cornell Medicine Department of Ophthalmology. Inclusion criteria included at least 6 months of DDI use and available ultra-widefield imaging. Patients were categorized as affected or unaffected based on retinal imaging assessed by two reviewers. The affected group was further divided into \u201cprobable\u201d or \u201cpossible\u201d retinopathy. Patient demographics, DDI usage characteristics, and imaging findings were analyzed with statistical comparisons drawn between affected and unaffected cohorts.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of the 127 patients, 9 (7%) showed signs of didanosine-induced retinal toxicity. On average, the affected group was older compared with the unaffected group (65.1 vs. 56.5 years, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.025), with lower BMI (23.2 vs. 27.4, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04), and older at the start of the treatment (51.6 vs. 40.8 years, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.026). Mild phenotypes with peripheral pigmentary changes were also identified using ultra-widefield imaging.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This pioneering academic study highlighted a notable prevalence of DDI-induced retinal toxicity. Statistical analysis demonstrated age, BMI, and age at treatment initiation as potential risk factors. Ultra-widefield autofluorescence emerged as a valuable tool in detecting and delineating findings. Follow-up studies are needed to determine the necessity of regular screening for individuals on or with a history of didanosine use.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004175","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T21:00:06Z","timestamp":1717621206000},"page":"1828-1835","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["PREVALENCE OF DIDANOSINE-RELATED RETINAL TOXICITY AT AN URBAN ACADEMIC CENTER AS DIAGNOSED WITH ULTRA-WIDEFIELD IMAGING"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6992-2781","authenticated-orcid":false,"given":"Joshua Seokju","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Weill Cornell Medical College, New York, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaffer","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Weill Cornell Medical College, New York, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanos","family":"Papakostas","sequence":"additional","affiliation":[{"name":"The Retina Institute of St. Louis, St Louis, Missouri."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Abdallah","family":"Mahrous","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Weill Cornell Medical College, New York, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald J.","family":"D'Amico","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Weill Cornell Medical College, New York, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilard","family":"Kiss","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Weill Cornell Medical College, New York, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle D.","family":"Kovacs","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Weill Cornell Medical College, New York, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250605","first-page":"278","article-title":"Drugs approved by the FDA in 1991","volume":"40","author":"Wynn","year":"1992","journal-title":"Gen Dent"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1097\/IAE.0000000000001267","article-title":"Didanosine retinal toxicity","volume":"36","author":"Haug","year":"2016","journal-title":"Retina"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9394(14)75744-7","article-title":"Retinal toxicity in human immunodeficiency virus\u2013infected children treated with 2\u2032, 3\u2032-dideoxyinosine","volume":"113","author":"Whitcup","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJM199204303261816","article-title":"Retinal lesions in children treated with dideoxyinosine","volume":"326","author":"Whitcup","year":"1992","journal-title":"N Engl J Med"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1001\/archopht.1994.01090240100033","article-title":"A clinicopathologic report of the retinal lesions associated with didanosine","volume":"112","author":"Whitcup","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/infdis\/168.4.810","article-title":"A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection","volume":"168","author":"Nguyen","year":"1993","journal-title":"J Infect Dis"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/00002030-199609000-00022","article-title":"Retinal toxicity associated with didanosine in HIV-infected adults","volume":"10","author":"Cobo","year":"1996","journal-title":"AIDS"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaophthalmol.2013.579","article-title":"Didanosine-associated retinal toxicity in adults infected with human immunodeficiency virus","volume":"131","author":"Gabrielian","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3389\/fneur.2021.663297","article-title":"Case report: multimodal imaging of toxic retinopathies related to human immunodeficiency virus antiretroviral therapies: maculopathy vs. peripheral retinopathy. Report of two cases and review of the literature","volume":"12","author":"Hammer","year":"2021","journal-title":"Front Neurol"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/j.jfo.2022.12.018","article-title":"Long-term follow-up with multimodal imaging and functional testing in didanosine retinal toxicity","volume":"46","author":"L\u00f3pez","year":"2023","journal-title":"J Fr Ophtalmol"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/24741264211044599","article-title":"Didanosine-associated retinal toxicity in a patient with a mutation in the CRB1 gene","volume":"6","author":"Lenis","year":"2022","journal-title":"J VitreoRetinal Dis"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1177\/0956462414554433","article-title":"A farewell to didanosine: harm reduction and cost savings by eliminating use of didanosine","volume":"26","author":"Dziuban","year":"2015","journal-title":"Int J STD AIDS"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/154510970200100105","article-title":"Update on didanosine","volume":"1","author":"Cooper","year":"2002","journal-title":"J Int Assoc Physicians AIDS Care"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"e0240906","DOI":"10.1371\/journal.pone.0240906","article-title":"Prevalence and factors associated with physical function limitation in older West African people living with HIV","volume":"15","author":"Bernard","year":"2020","journal-title":"PLoS One"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1212\/WNL.0b013e3181aae814","article-title":"Ophthalmoplegia and ptosis: mitochondrial toxicity in patients receiving HIV therapy","volume":"73","author":"Pfeffer","year":"2009","journal-title":"Neurology"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"R244","DOI":"10.1093\/hmg\/ddl233","article-title":"Mitochondrial DNA polymerase-\u03b3 and human disease","volume":"15 Spec No 2","author":"Hudson","year":"2006","journal-title":"Hum Mol Genet"},{"key":"R20-20250605","first-page":"1","article-title":"Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells","volume":"33","author":"Gao","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/IIO.0b013e31823bbad5","article-title":"Retinal toxicity of systemic medications","volume":"52","author":"Labriola","year":"2012","journal-title":"Int Ophthalmol Clin"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10633-015-9521-y","article-title":"A possible early sign of hydroxychloroquine macular toxicity","volume":"132","author":"Brandao","year":"2016","journal-title":"Documenta Ophthalmologica"},{"key":"R24-20250605","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/humu.21653","article-title":"CRB1 mutations in inherited retinal dystrophies","volume":"33","author":"Bujakowska","year":"2012","journal-title":"Hum Mutat"},{"key":"R25-20250605","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/ajmg.a.34071","article-title":"A loss of function mutation in the COL9A2 gene causes autosomal recessive Stickler syndrome","volume":"155A","author":"Baker","year":"2011","journal-title":"Am J Med Genet A"},{"key":"R26-20250605","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0002-9394(84)90686-X","article-title":"Senile reticular pigmentary degeneration","volume":"98","author":"Humphrey","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"R27-20250605","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1345\/aph.1C412","article-title":"Effect of tenofovir on didanosine absorption in patients with HIV","volume":"37","author":"Pecora Fulco","year":"2003","journal-title":"Ann Pharmacother"},{"key":"R28-20250605","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/sj.eye.6702298","article-title":"Didanosine-induced retinopathy in adults can be reversible","volume":"20","author":"Fernando","year":"2006","journal-title":"Eye"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:02:56Z","timestamp":1749142976000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004175","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}